| Literature DB >> 23530910 |
Wachiraporn Wanichnopparat1, Kulachanya Suwanwongse, Piyapat Pin-On, Chatchawit Aporntewan, Apiwat Mutirangura.
Abstract
BACKGROUND: Thousands of intragenic long interspersed element 1 sequences (LINE-1 elements or L1s) reside within genes. These intragenic L1 sequences are conserved and regulate the expression of their host genes. When L1 methylation is decreased, either through chemical induction or in cancer, the intragenic L1 transcription is increased. The resulting L1 mRNAs form RISC complexes with pre-mRNA to degrade the complementary mRNA. In this study, we screened for genes that are involved in intragenic L1 regulation networks.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23530910 PMCID: PMC3643820 DOI: 10.1186/1471-2164-14-205
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1The CU-DREAM extension program. (A) A flow chart illustrating how the microarray data were processed. First, the microarray data for the fields of interest were collected and prepared. The program then computed the status of each gene (upregulated or downregulated) using Student’s t-test. Subsequently, the assessed genes were compared with a list of genes containing intragenic L1s. The results showed the associations between the gene regulation status and the presence of an L1 sequence in terms of ORs and p-values. (B) A table indicating the intersection between each experimental result and the genes containing intragenic L1s. These intersections are referred to as groups A through D. Group A includes the genes that are upregulated or downregulated and contain intragenic L1s. Group B includes the genes that are not upregulated or downregulated but contain intragenic L1s. Group C includes the genes that are upregulated or downregulated but do not contain intragenic L1s. Group D includes the remaining genes, which are not upregulated or downregulated and do not contain intragenic L1s.
A summary of the assessed gene knockdown experiments
| Down and Up < 1 | 0 | 0 | 0 | 0 |
| Down and Up > 1 | 7 | 4 | 1 | 2 |
| Down < 1 | 9 | 10 | 1 | 0 |
| Down > 1 | 40 | 26 | 13 | 2 |
| Up < 1 | 12 | 11 | 3 | 0 |
| Up > 1 | 39 | 32 | 8 | 4 |
| non-significant | 409 | 172 | 241 | 13 |
A 2 × 2 table indicating the results of the siRNA experiment, which exhibited an OR in the downregulation direction
| 28 | 1,312 | | |
|---|---|---|---|
| 169 | 18,865 | ||
A 2 × 2 table indicating the results of an siRNA experiment, which exhibited an OR in the upregulation direction
| 22 | 1,315 | | |
|---|---|---|---|
| 143 | 18,976 | ||
Figure 2The pie chart illustrates the number of genes and the official gene names for the siRNA experiments. The results are grouped in terms of the direction of the expression change, the OR and the q-value.
Figure 3The diagram shows the 4 groups of significant siRNA genes that are associated with strand of L1s: (1) siRNA genes that were associated with genes containing sense L1s or antisense L1s (+, +), (2) siRNA genes that were associated with genes containing only sense L1s (+, -), (3) siRNA genes that were associated with genes containing only antisense L1s (−, +) and (4) siRNA genes that were not associated with genes containing sense L1s or antisense L1s (−, -) but were associated with genes containing both sense and antisense L1s.
Genes with more than one expression profile
| non-significant and significant | Differences in cell types, oligomer sets, cell passages, cell treatments and times of transfection | |
| Different regulation direction | Differences in cell types, oligomer sets, cell passages, platforms, cell treatments and times of transfection | |
| Same regulation direction | Differences in cell types, oligomer sets, cell passages, platforms, cell treatments and times of transfection |
Figure 4The figure shows the molecular functions, the molecular and cellular phenotypes and the associated diseases and abnormalities of significant siRNA genes.